Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (the "Company") on April 1, 2019. The filing discloses the entry into a Material Definitive Agreement regarding a new equity financing facility.
Key Financial Metrics and Transaction Details
- Agreement Type: Common Stock Purchase Agreement (CSPA) establishing an equity line of credit.
- Counterparty: Oasis Capital, LLC.
- Total Capacity: Up to 20,000,000 shares of Common Stock.
- Purchase Price: Fixed at $0.28 per share (subject to adjustment).
- Maximum Potential Proceeds: Approximately $5.6 million (20,000,000 shares x $0.28).
- Transaction Expenses: Anticipated to be approximately $58,000.
- Use of Proceeds: General corporate purposes and working capital.
- Financial Statements: This filing does not contain revenue, profit, cash flow, or debt metrics for the Company.
Material Changes and Terms
The Company has secured a new source of liquidity through an "Equity Line Offering." Key terms include:
- Issuance Mechanism: The Company may direct Oasis Capital to purchase shares via "Purchase Notices" at its sole discretion.
- Volume Limits: Each purchase is limited to the lesser of 500,000 shares or 200% of the average trading volume over the preceding 5 trading days.
- Frequency Limits: No more than one Purchase Notice may be submitted in any 3-trading-day period without consent.
- Ownership Cap: Purchases are restricted to prevent Oasis Capital from exceeding 9.99% beneficial ownership of outstanding Common Stock.
- Expansion Option: The Company may increase the facility by an additional 20,000,000 shares after the effective date.
Outlook, Risks, and Contingencies
The filing includes standard forward-looking statements regarding the use of proceeds. The Company notes that it does not plan to publicly update these statements. Risks include the potential dilution of existing shareholders and the Company's ability to issue shares without breaching NASDAQ Capital Market rules. The agreement contains customary representations, warranties, and indemnification obligations.
Investor Verification Checklist
- Verify the current trading volume of Jaguar Health stock to assess the practical limit of share sales per notice (200% of 5-day average).
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) for specific adjustment mechanisms to the $0.28 purchase price.
- Monitor future filings to determine if the Company exercises the option to increase the facility by an additional 20,000,000 shares.
- Check subsequent 10-Q or 10-K filings for actual drawdowns on this facility and the resulting impact on cash flow and share count.